ADVANCED SOLID TUMORS HARBORING RAS MUTATIONS OR AMPLIFICATIONS
Clinical trials for ADVANCED SOLID TUMORS HARBORING RAS MUTATIONS OR AMPLIFICATIONS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID TUMORS HARBORING RAS MUTATIONS OR AMPLIFICATIONS trials appear
Sign up with your email to follow new studies for ADVANCED SOLID TUMORS HARBORING RAS MUTATIONS OR AMPLIFICATIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets Hard-to-Treat cancers with RAS mutations
Disease control Recruiting nowThis early-stage study tests an experimental drug called HRS-2329 in people with advanced solid tumors that have RAS mutations or amplifications. The main goals are to check the drug's safety, find the best dose, and see how the body processes it. About 120 participants will take…
Matched conditions: ADVANCED SOLID TUMORS HARBORING RAS MUTATIONS OR AMPLIFICATIONS
Phase: PHASE1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New hope for Hard-to-Treat cancers: HRS-7172 enters human trials
Disease control Recruiting nowThis early-stage study tests a new drug called HRS-7172 in people with advanced solid tumors that have RAS mutations or amplifications. The main goals are to check safety, find the best dose, and see how the body processes the drug. About 120 adults aged 18-75 with good organ fun…
Matched conditions: ADVANCED SOLID TUMORS HARBORING RAS MUTATIONS OR AMPLIFICATIONS
Phase: PHASE1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC